Evidence map›Paper›PMID 38690930›Full record

ArticleAmerican journal of physiology. Cell physiology2024

IGF1 promotes human myotube differentiation toward a mature metabolic and contractile phenotype.

Simon I Dreher, Paul Grubba, Christine von Toerne, Alessia Moruzzi, Jennifer Maurer, Thomas Goj, Andreas L Birkenfeld, Andreas Peter, Peter Loskill, Stefanie M Hauck and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Physical Activity, Exerkines, and Their Role in Cancer Cachexia.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Simon I DreherDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0002-8266-1624
Paul GrubbaDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Christine von ToerneMetabolomics and Proteomics Core Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Alessia MoruzziNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Jennifer MaurerDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Thomas GojDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.
Andreas L BirkenfeldGerman Center for Diabetes Research (DZD), Neuherberg, Germany.
Andreas PeterDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0001-5732-2287
Peter LoskillNMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
Stefanie M HauckMetabolomics and Proteomics Core Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.ORCID 0000-0002-1630-6827
Cora WeigertDepartment for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0003-0358-776X
Helmholtz Zentrum München · DEUniversity of Tübingen · DENatural and Medical Sciences Institute · DEDeutsches Diabetes-Zentrum e.V. · DE

Funding

Bundesministerium für Bildung und Forschung (BMBF) 01GI0925Deutsche Diabetes Gesellschaft (DDG) Allgemeine Projektförderung
6 · The paper itself

Abstract

Skeletal muscle mediates the beneficial effects of exercise, thereby improving insulin sensitivity and reducing the risk for type 2 diabetes. Current human skeletal muscle models in vitro are incapable of fully recapitulating its physiological functions especially muscle contractility. By supplementation of insulin-like growth factor 1 (IGF1), a growth factor secreted by myofibers in vivo, we aimed to overcome these limitations. We monitored the differentiation process starting from primary human CD56-positive myoblasts in the presence/absence of IGF1 in serum-free medium in daily collected samples for 10 days. IGF1-supported differentiation formed thicker multinucleated myotubes showing physiological contraction upon electrical pulse stimulation (EPS) following

Indexed as

Cell DifferentiationInsulin-Like Growth Factor IMuscle ContractionMuscle Fibers, SkeletalPhenotypeCells, CulturedGlucoseGlucose Transporter Type 4HumansMuscle, SkeletalMyosin Heavy ChainsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaGlucoseGlucose Transporter Type 4IGF1 protein, humanInsulin-Like Growth Factor IMyosin Heavy ChainsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanSLC2A4 protein, humancontractionEPSGLUT4human myotubesproteomics

Identifiers

PMID38690930
PMCPMC11371365
OpenAlexW4392370714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.